Steph & CO Catalent, Inc. Transaction History

Steph & CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 11, 2022	BUY	$72.36 - $113.1 $5,571 - $8,708	77 Added 4.22%	1,901 $138,000
Q2 2022 Jul 13, 2022	BUY	$87.2 - $114.05 $29,037 - $37,978	333 Added 22.33%	1,824 $196,000
Q1 2022 Apr 15, 2022	SELL	$94.19 - $124.49 $6,122 - $8,091	-65 Reduced 4.18%	1,491 $165,000
Q4 2021 Jan 24, 2022	BUY	$119.57 - $139.07 $60,382 - $70,230	505 Added 48.05%	1,556 $199,000
Q4 2020 Jan 29, 2021	SELL	$85.88 - $105.36 $14,943 - $18,332	-174 Reduced 14.2%	1,051 $109,000
Q2 2020 Jul 15, 2020	BUY	$48.02 - $79.04 $19,880 - $32,722	414 Added 51.05%	1,225 $90,000
Q1 2020 Apr 14, 2020	BUY	$36.95 - $62.95 $29,966 - $51,052	811 New	811 $42,000

514

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Steph & CO, based on Form 13F filings with the SEC.

Stay updated on Steph & CO with notifications on news.